HomeCompareVCCTF vs PFE

VCCTF vs PFE: Dividend Comparison 2026

VCCTF yields 644.33% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VCCTF wins by $481.2K in total portfolio value
10 years
VCCTF
VCCTF
● Live price
644.33%
Share price
$0.31
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$530.7K
Annual income
$1,692.20
Full VCCTF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — VCCTF vs PFE

📍 VCCTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVCCTFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VCCTF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VCCTF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VCCTF
Annual income on $10K today (after 15% tax)
$54,768.04/yr
After 10yr DRIP, annual income (after tax)
$1,438.37/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $20,881.53/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VCCTF + PFE for your $10,000?

VCCTF: 50%PFE: 50%
100% PFE50/50100% VCCTF
Portfolio after 10yr
$290.1K
Annual income
$13,975.46/yr
Blended yield
4.82%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

VCCTF
No analyst data
Altman Z
0.6
Piotroski
4/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VCCTF buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVCCTFPFE
Forward yield644.33%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%13.2%
Portfolio after 10y$530.7K$49.6K
Annual income after 10y$1,692.20$26,258.71
Total dividends collected$329.7K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VCCTF vs PFE ($10,000, DRIP)

YearVCCTF PortfolioVCCTF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$42,916$32,216.49$9,153$693.39+$33.8KVCCTF
2$110,529$64,608.37$8,593$849.25+$101.9KVCCTF
3$196,021$77,754.77$8,336$1,066.78+$187.7KVCCTF
4$274,180$64,437.57$8,437$1,384.80+$265.7KVCCTF
5$335,490$42,117.13$9,013$1,875.40+$326.5KVCCTF
6$383,056$24,081.77$10,306$2,680.72+$372.8KVCCTF
7$422,718$12,848.65$12,820$4,101.38+$409.9KVCCTF
8$458,934$6,625.72$17,673$6,826.70+$441.3KVCCTF
9$494,421$3,361.39$27,543$12,591.86+$466.9KVCCTF
10$530,723$1,692.20$49,560$26,258.71+$481.2KVCCTF

VCCTF vs PFE: Complete Analysis 2026

VCCTFStock

Victoria PLC, together with its subsidiaries, designs, manufactures, and distributes flooring products primarily in the United Kingdom, Spain, Italy, the Netherlands, Belgium, Turkey, the United States, and Australia. The company operates through four segments: UK & Europe Soft Flooring, UK & Europe Ceramic Tiles, Australia, and North America. It offers a range of wool and synthetic broadloom carpets, ceramic and porcelain tiles, flooring underlays, luxury vinyl tiles (LVT), hardwood flooring products, artificial grass, carpet tiles, and flooring accessories, as well as markets and distributes LVT and hardwood flooring products. The company also offers logistics services. It provides its products under various brands. The company was founded in 1895 and is headquartered in Kidderminster, the United Kingdom.

Full VCCTF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this VCCTF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VCCTF vs SCHDVCCTF vs JEPIVCCTF vs OVCCTF vs KOVCCTF vs MAINVCCTF vs JNJVCCTF vs MRKVCCTF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.